Mirjam Kuipers

864 citations

27 papers · 647 indexed · h-index 15

Impact in

Virology top 10%
- HIV Research and Treatment
Urology top 5%
- Urinary Bladder and Prostate Research

Papers in

Virology 7
- HIV Research and Treatment 7
Urology 5
- Urinary Bladder and Prostate Research 5

Co-authors: Pieter Swart Dirk K. F. Meijer Walter Krauwinkel H. G. de Vries Cees Korstanje Martin C. Michel Leonie Beljaars Ronald Smulders
Journals: Biochemical Pharmacology (2 papers)Journal of Clinical Oncology (2 papers)Journal of Peptide Science (2 papers)Clinical Cancer Research (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)
Partner nations: Netherlands Germany United States

In The Last Decade

Mirjam Kuipers

27 papers receiving 618 citations

Peers

Countries citing papers authored by Mirjam Kuipers

Since Specialization

Citations

This map shows the geographic impact of Mirjam Kuipers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam Kuipers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam Kuipers more than expected).

Fields of papers citing papers by Mirjam Kuipers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjam Kuipers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam Kuipers. The network helps show where Mirjam Kuipers may publish in the future.

Co-authors

The 25 scholars most cited alongside Mirjam Kuipers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mirjam Kuipers Line = papers co-authored together Mirjam Kuipers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer Clinical Cancer Research ·Paul B. Romesser, Jaume Capdevila, Rocio García‐Carbonero, Tony Philip, Carlos Fernández-Martos, Richard Tuli, Gunjan Chawla, Mirjam Kuipers, Jorge Luiz Alaves Silva, Anna Coenen-Stass, Vinicius Haas Ilgenfritz, Greg Fountas, Eric D. Miller	2023	17
2	A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors International Journal of Radiation OncologyBiologyPhysics ·Michael A. Samuels, John F. Lowney, Voichita Bar‐Ad, Juergen Dunst, Baukelien van Triest, Jeffrey Yachnin, Gunjan Chawla, Mirjam Kuipers, Greg Fountas, Vinicius Haas Ilgenfritz, Giuseppe Locatelli, Jorge Luiz Alaves Silva, Esther G.C. Troost	2023	36
3	A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours British Journal of Cancer ·Mark T. J. van Bussel, Ahmad Awada, Maja J.A. de Jonge, Morten Mau‐Sørensen, Dorte Nielsen, Patrick Schöffski, Henk M.W. Verheul, Vinicius Haas Ilgenfritz, Karin Berghoff, Samer El Bawab, Mirjam Kuipers, Lars Damstrup, Iván Díaz-Padilla, Jan H.M. Schellens	2020	75
4	Safety, clinical activity and pharmacological biomarker evaluation of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814: Results from two phase I trials Annals of Oncology ·Morten Mau‐Sørensen, Vivek Mariappan, Mirjam Kuipers, Ricardo Oliveira Falcão, Henk M.W. Verheul, Philippe Aftimos, Maja J.A. de Jonge, Baukelien van Triest, John F. Lowney, Jürgen Debus, Esther G.C. Troost, M.A. Samuels, Vinicius Haas Ilgenfritz, Volker Budach, Sanjay Goel, Giuseppe Locatelli, Poul Geertsen	2018	13
5	Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady‐state pharmacokinetics of digoxin in healthy subjects British Journal of Clinical Pharmacology ·Ronald Smulders, Mirjam Kuipers, Walter Krauwinkel	2006	9
6	Open-Label Study of the Safety and Pharmacokinetics of Solifenacin in Subjects With Hepatic Impairment Journal of Pharmacological Sciences ·Mirjam Kuipers, Ronald Smulders, Walter Krauwinkel, Joe Bond	2006	17
7	Pharmacokinetic interaction of solifenacin with an oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women: A double-blind, placebo-controlled study Clinical Therapeutics ·Paul A. Booth, M.A. Nadil, Mirjam Kuipers, Walter Krauwinkel, N Visser, Ronald Smulders	2005	12
8	Prediction of the pharmacokinetics of succinylated human serum albumin in man from in vivo disposition data in animals and in vitro liver slice incubations European Journal of Pharmaceutical Sciences ·Johannes H. Proost, Leonie Beljaars, Peter Olinga, Pieter Swart, Mirjam Kuipers, Catharina Reker‐Smit, Geny M. M. Groothuis, Dirk K. F. Meijer	2005	10
9	Amoxicillin/clavulanic acid (875/125): bioequivalence of a novel Solutab tablet and rationale for a twice-daily dosing regimen International Journal of Clinical Pharmacology and Therapeutics ·Hildegard Sourgens, Shoji MURAI, N. Hampp, Mirjam Kuipers, Ans Botchway	2004	3
10	Solifenacin Demonstrates High Absolute Bioavailability in Healthy Men Drugs in R&D ·Mirjam Kuipers, Walter Krauwinkel, Hans Mulder, N Visser	2004	24
11	Design and Fungicidal Activity of Mucoadhesive Lactoferrin Tablets for the Treatment of Oropharyngeal Candidosis Drug Delivery ·Mirjam Kuipers, Carlos Giuliani, Hester I. Bakker, D. K. F. Meijer, Pieter Swart, Henderik W. Frijlink, 舒慧珠, H. G. de Vries-Hospers, Jeroen J.M. van den Berg	2002	26
12	Conditions influencing the in vitro antifungal activity of lactoferrin combined with antimycotics against clinical isolates of Candida Apmis ·Mirjam Kuipers, Leonie Beljaars, Nina van Beek, H. G. de Vries, Janette Heegsma, Jeroen J.M. van den Berg, D. K. F. Meijer, P. J. Swart	2002	13
13	The Metabolic Fate of the Anti-HIV Active Drug Carrier Succinylated Human Serum Albumin after Intravenous Administration in Rats Journal of drug targeting ·P. J. Swart, Mirjam Kuipers, Cees Smit, Leonie Beljaars, Khaled Ebrahim El Nweiam, D. K. F. Meijer	2001	4
14	Plasma Lactoferrin Levels Are Decreased in End-Stage AIDS Patients Viral Immunology ·Emilia. Lombardi, Martin C. Harmsen, T H Thé, Afrah QALI, Heder de Vries, Thái Hoàng Phạm, Mirjam Kuipers, Dirk K. F. Meijer, Pieter Swart	1999	32
15	Mechanism of anti-HIV activity of succinylated human serum albumin Biochemical Pharmacology ·Mirjam Kuipers, Marjan van den Berg, Pieter Swart, Jon D. Laman, Dirk K. F. Meijer, Marco Koppelman, Han G. Huisman	1999	16
16	Targeting of superoxide dismutase to the liver results in anti-inflammatory effects in rats with fibrotic livers Journal of Hepatology ·Pieter Swart, Takashi Hirano, Mirjam Kuipers, Yuko Ito, 勇橋口, Mitsuru Hashida, Makiya Nishikawa, Leonie Beljaars, Dirk K. F. Meijer, Klaas Poelstra	1999	31
17	Homing of negatively charged albumins to the lymphatic system Biochemical Pharmacology ·Pieter Swart, Leonie Beljaars, Mirjam Kuipers, 勇橋口, Paul Nieuwenhuis, Dirk K. F. Meijer	1999	26
18	Charge modification of plasma and milk proteins results in antiviral active compounds Journal of Peptide Science ·Pieter Swart, Martin C. Harmsen, Mirjam Kuipers, Alice Van Wart, M. Perminova, Gianni Minà, Jan H. Nuijens, 勇橋口, Wendy Maribel Cárdenas Quispe, Erik De Clercq, Yu Shi, Rudi Pauwels, Dirk K. F. Meijer	1999	40
19	Charge modification of plasma and milk proteins results in antiviral active compounds Journal of Peptide Science ·Pieter Swart, Martin C. Harmsen, Mirjam Kuipers, Alice Van Wart, M. Perminova, Gianni Minà, Jan H. Nuijens, 勇橋口, Wendy Maribel Cárdenas Quispe, Erik De Clercq, Yu Shi, Rudi Pauwels, Dirk K. F. Meijer	1999	3
20	Pharmacokinetics and anti-HIV-1 efficacy of negatively charged human serum albumins in mice Antiviral Research ·Mirjam Kuipers, P. J. Swart, Martin Schutten, Cees Smit, Johannes H. Proost, Albert D. M. E. Osterhaus, G. ZHANG	1997	10

About Mirjam Kuipers

Mirjam Kuipers is a scholar working on Virology, Urology, Emergency Medical Services, Nutrition and Dietetics and Oncology, having authored 27 papers that have together received 647 indexed citations. Recurring topics across this work include HIV Research and Treatment (7 papers), Infant Nutrition and Health (6 papers), Urinary Bladder and Prostate Research (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Pediatric health and respiratory diseases (3 papers), HIV/AIDS drug development and treatment (3 papers) and Pelvic floor disorders treatments (2 papers). The work is most often cited by research in Virology (63 citations), Urology (82 citations), Nutrition and Dietetics (126 citations), Microbiology (45 citations) and Infectious Diseases (131 citations). Mirjam Kuipers has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Pieter Swart, Dirk K. F. Meijer, Walter Krauwinkel, H. G. de Vries, Cees Korstanje, Martin C. Michel, Leonie Beljaars, Ronald Smulders, Erik De Clercq and Rudi Pauwels. Their work appears in journals such as Biochemical Pharmacology, Journal of Clinical Oncology, Journal of Peptide Science, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact